CHEN N, ZHANG P, FAN F, JIN H, CHEN Y, LIU J, CHEN L, WAN X, GUO J, YANG Z, SUN L, SHAN H, YU D, WANG Z und SHI J, 2026. Development of a risk assessment model for multimorbidity of diabetes, hypertension, and coronary heart disease with XGBoost in primary care in Shanghai, China: a retrospective study. BMC cardiovascular disorders. 5 Januar 2026. Vol. 26, no. 1, p. 103-103. DOI 10.1186/s12872-025-05479-w.
Elsevier - Harvard (with titles)Chen N, Zhang P, Fan F, Jin H, Chen Y, Liu J, Chen L, Wan X, Guo J, Yang Z, Sun L, Shan H, Yu D, Wang Z, Shi J, 2026. Development of a risk assessment model for multimorbidity of diabetes, hypertension, and coronary heart disease with XGBoost in primary care in Shanghai, China: a retrospective study. BMC cardiovascular disorders 26, 103-103. https://doi.org/10.1186/s12872-025-05479-w
American Psychological Association 7th editionChen N, Zhang P, Fan F, Jin H, Chen Y, Liu J, Chen L, Wan X, Guo J, Yang Z, Sun L, Shan H, Yu D, Wang Z, & Shi J. (2026). Development of a risk assessment model for multimorbidity of diabetes, hypertension, and coronary heart disease with XGBoost in primary care in Shanghai, China: a retrospective study. BMC Cardiovascular Disorders, 26(1), 103-103. https://doi.org/10.1186/s12872-025-05479-w
Springer - Basic (author-date)Chen N, Zhang P, Fan F, Jin H, Chen Y, Liu J, Chen L, Wan X, Guo J, Yang Z, Sun L, Shan H, Yu D, Wang Z, Shi J (2026) Development of a risk assessment model for multimorbidity of diabetes, hypertension, and coronary heart disease with XGBoost in primary care in Shanghai, China: a retrospective study.. BMC cardiovascular disorders 26:103-103. https://doi.org/10.1186/s12872-025-05479-w
Juristische Zitierweise (Stüber) (Deutsch)Chen N/ Zhang P/ Fan F/ Jin H/ Chen Y/ Liu J/ Chen L/ Wan X/ Guo J/ Yang Z/ Sun L/ Shan H/ Yu D/ Wang Z/ Shi J, Development of a risk assessment model for multimorbidity of diabetes, hypertension, and coronary heart disease with XGBoost in primary care in Shanghai, China: a retrospective study., BMC cardiovascular disorders 2026, 103-103.